Neurogenesis Is Increased in Human Neural Stem Cells by Aβ40 Peptide.
Adela Bernabeu-ZornozaRaquel CoronelCharlotte PalmerAlberto MartínVictoria LópezIsabel ListePublished in: International journal of molecular sciences (2022)
Amyloid-β 40 peptides [Aβ1-40 (Aβ40)] are present within amyloid plaques in the brains of patients with Alzheimer's disease (AD). Even though Aβ peptides are considered neurotoxic, they can mediate many biological processes, both in adult brains and throughout brain development. However, the physiological function of these Aβ peptides remains poorly understood, and the existing data are sometimes controversial. Here, we analyze and compare the effects of monomeric Aβ40 on the biology of differentiating human neural stem cells (human NSCs). For that purpose, we used a model of human NSCs called hNS1. Our data demonstrated that Aβ40 at high concentrations provokes apoptotic cellular death and the damage of DNA in human NSCs while also increasing the proliferation and favors neurogenesis by raising the percentage of proliferating neuronal precursors. These effects can be mediated, at least in part, by β-catenin. These results provide evidence of how Aβ modulate/regulate human NSC proliferation and differentiation, suggesting Aβ40 may be a pro-neurogenic factor. Our data could contribute to a better understanding of the molecular mechanisms involved in AD pathology and to the development of human NSC-based therapies for AD treatment, since these results could then be used in diagnosing the disease at early stages and be applied to the development of new treatment options.
Keyphrases
- endothelial cells
- induced pluripotent stem cells
- pluripotent stem cells
- cell death
- computed tomography
- epithelial mesenchymal transition
- spinal cord injury
- machine learning
- cell proliferation
- single molecule
- young adults
- white matter
- subarachnoid hemorrhage
- anti inflammatory
- cognitive decline
- circulating tumor
- mild cognitive impairment
- resting state